{"nctId":"NCT02731638","briefTitle":"Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers","startDateStruct":{"date":"2016-09","type":"ACTUAL"},"conditions":["Corneal Ulcer","Fungal Keratitis"],"count":70,"armGroups":[{"label":"Intrastromal voriconazole plus natamycin","type":"EXPERIMENTAL","interventionNames":["Drug: Intrastromal voriconazole","Drug: Natamycin"]},{"label":"Natamycin alone","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Natamycin"]}],"interventions":[{"name":"Intrastromal voriconazole","otherNames":[]},{"name":"Natamycin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Moderate to severe corneal ulcer that is smear positive for filamentous fungus\n* Pinhole visual acuity worse than 20/70 in affected eye\n* Basic understanding of the study as determined by the physician\n* Commitment to return for follow up visits\n\nExclusion Criteria:\n\n* Gram stain positive for bacteria or evidence of other concomitant infection (i.e. herpes, acanthamoeba)\n* Impending or frank perforation at recruitment\n* Involvement of sclera at presentation\n* Non-infectious or autoimmune keratitis\n* History of corneal transplantation or recent intraocular surgery\n* No light perception in the affected eye\n* Pinhole visual acuity worse than 20/200 in the unaffected eye\n* Pregnant women\n* Participants who are decisionally and/or cognitively impaired","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Culture Positivity at Day 3 Using Potassium Hydroxide (KOH) Wet Mount to Test for Fungus","description":"Number of of participants with positive fungal cultures at 3 days","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"SECONDARY","title":"Best Spectacle-corrected Visual Acuity, as Measured by a Refractionist","description":"Best spectacle-corrected visual acuity using calibrated Original Series Early Treatment Diabetic Retinopathy Study eye charts and recorded as number of letter read.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.39","spread":"0.59"},{"groupId":"OG001","value":"1.23","spread":"0.65"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.30","spread":"0.60"},{"groupId":"OG001","value":"1.28","spread":"0.66"}]}]}]},{"type":"SECONDARY","title":"Scar Size","description":"Scar size, geometric mean","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":"1.2"},{"groupId":"OG001","value":"4.1","spread":"1.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.9","spread":"1.2"},{"groupId":"OG001","value":"4.5","spread":"1.1"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Scar Depth at the Anterior Third, Middle Third, and Posterior Third of the Cornea","description":"Number of participants with scar depth at the anterior third (0-33% depth), middle third (\\>33-67% depth), and posterior third (\\>67-100% depth) of the cornea, as measured on slit lamp exam.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"13","spread":null}]},{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"7","spread":null}]},{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"2","spread":null}]},{"measurements":[{"groupId":"OG000","value":"5","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Corneal Thinning, as Measured by Pachymetry and OCT","description":null,"classes":[]},{"type":"SECONDARY","title":"Corneal Topography, as Measured by a Non-contact Imaging Topographer","description":null,"classes":[]},{"type":"SECONDARY","title":"Change in Quality of Life, Measured by the Indian Vision Function Questionnaire (IND-VFQ)","description":null,"classes":[]},{"type":"SECONDARY","title":"Corneal Neovascularization","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":35},"commonTop":["Therapeutic Penetrating Keratoplasty","Perforation","Glaucoma","Hypopyon","Nonhealing Ulcer"]}}}